
Conference Call with Corona Remedies Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.

Conference Call with Corona Remedies Management and Analysts on Q2FY26 Performance and Outlook. Listen to the full earnings transcript.
